Abbott Labs Q4 Earnings: Analysts Predict 11.9% Jump

Abbott Laboratories, a healthcare giant with a $217B market cap, is set to report Q4 2025 earnings. Analysts predict a 11.9% YoY increase to $1.50 per share. The company has consistently met or exceeded expectations for the past four quarters, with Q3 EPS at $1.30, matching forecasts. Despite a 6.9% YoY sales growth to $11.4B, shares fell 2.9% in October due to slightly missed sales estimates and weaker diagnostics revenue. Full-year 2025 profits are projected at $5.15 per share, a 10.3% increase from 2024, with another 9.9% growth to $5.66 in 2026. While Abbotts stock has gained 8.8% over the past 52 weeks, it lags the S&P 500s 14.8% and the healthcare sector ETFs 11.8%. Investors eagerly await earnings to gauge potential momentum.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.